View Older Stories View More Recent Stories
-
Tilray, Inc. (TLRY) call put ratio 3 calls to 1 put into quarter results
-
Tilray Inc (TLRY:CN) (TLRY) PT Raised to Cdn$13.60 at Bernstein SocGen Group
-
Tilray (TLRY) Stock Sees a Substantial PT Lift at Bernstein After Cannabis Rescheduling
-
Tilray launches US medical cannabis unit after federal rescheduling
-
Trump signs order easing federal restrictions on marijuana
-
Trump: order will not legalize marijuana in any way
-
Trump To Sign Order To Reclassify Marijuana - Bloomberg
-
Trump to sign executive order expediting marijuana reclassification
-
Trump to sign order on marijuana as soon as today - ABC
-
Trump: Considering Order To Reclassify Marijuana
-
Trump to Sign Order Reclassifying Cannabis Monday - CNBC
-
Cannabis stocks climb as Trump weighs marijuana rescheduling
-
Tilray (TLRY) PT Lowered to $10 at TD Cowen
-
Tilray implements 1-for-10 reverse stock split effective December 1
-
Medicare testing to make CBD treatments available to seniors, Bloomberg reports
-
Tilray Medical enters Panama through joint venture partnership
-
Tilray, Inc. (TLRY) files mixed shelf
-
Tilray, Inc. (TLRY) Tops Q1 EPS by 4c
-
Tilray, Inc. (TLRY) October 10 weekly calls active into quarter results
-
Tilray, Inc. (TLRY) call put ratio 15.9 calls to 1 put into the expected release of quarter results
-
Tilray, Inc. (TLRY) call put ratio 14.5 calls to 1 put as share price up 42%
-
TLRY launches oktoberfest seasonal beer lineup across five breweries
-
Breckenridge Distillery taps Winebow for California distribution
-
Increasing unusual call option volume: ALTS OHI ARWR GDRX KDP ASST AEHR BBD PDD OPEN TLRY
-
Tilray (TLRY) PT Raised to $2 at Jefferies
-
Increasing unusual call option volume: ALTS AMCR APD DLO EQX BIRK AEO FND CLBT PSQH WULF TLRY
-
Tilray requests extension to meet NASDAQ listing requirements
-
Tilray Medical partners with Italian firm to expand cannabis access
-
Jefferies Reiterates Buy Rating on Tilray (TLRY)
-
Tilray, Inc. (TLRY) Tops Q4 EPS by 4c; offers guidance
-
Tilray, Inc. (TLRY) Approve 1:10 to 1:20 Reverse Stock Split, Pauses Implementation as It Evaluates Timing and Stock Price
-
Tilray (TLRY) PT Lowered to $20 at Needham
-
Tilray, Inc. (TLRY) Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders
-
Tilray (TLRY) PT Lowered to $1.50 at Jefferies
-
Tilray, Inc. (TLRY) Tops Q3 EPS by 4c; lowers guidance
-
Tilray (TLRY) PT Lowered to $1 at TD Cowen
-
Tilray, Inc. (TLRY) Grows Non-Alcoholic Craft Beer Line
-
Jefferies Reiterates Buy Rating on Tilray (TLRY)
-
Tilray (TLRY) PT Lowered to $1.50 at TD Cowen as Canadian Adult-Use Cannabis Continues to Drag
-
Tilray, Inc. (TLRY) Tops Q2 EPS by 4c ; Offers Guidance
-
Tilray, Inc. (TLRY) call put ratio 13.7 calls to 1 put into quarter results
-
Tilray, Inc. (TLRY) Announces Premium Non-Alcohol Beverage Lineup
-
Tilray, Inc. (TLRY) Announces Fall Craft Beer Lineup
-
Tilray (TLRY) PT Lowered to $1.75 at Roth/MKM, 'organic growth remains elusive'
-
Piper Sandler Reiterates Neutral Rating on Tilray (TLRY)
-
Jefferies Reiterates Buy Rating on Tilray (TLRY)
-
Tilray, Inc. (TLRY) Tops Q1 EPS by 3c
-
Tilray, Inc. (TLRY) call put ratio 29 calls to 1 put with focus on October 11 weekly 2 calls into quarter results
-
Tilray, Inc. (TLRY) call put ratio 9.5 calls to 1 put with focus on October 11 weekly calls
-
Tilray, Inc. (TLRY) call put ratio 28 calls to 1 put with focus on October 4 weekly calls into quarter results
